2003
DOI: 10.1016/s0953-6205(03)91566-4
|View full text |Cite
|
Sign up to set email alerts
|

P303 Impact of HAART in HIV patients with multicentric Castleman's disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2015
2015
2015
2015

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…This unmasking of an occult disease after initiation of antiretroviral therapy is referred to as immune reconstitution inflammatory syndrome (IRIS). While it is recognised that Kaposi's sarcoma tends to improve with HAART, data regarding the effect of HAART on multicentric Castleman's disease is conflicting [2,3] . While some report successful treatment of the condition with HAART alone, others claim that multicentric Castleman's disease does not regress with HAART alone [2][3][4] .…”
Section: Case Presentationmentioning
confidence: 99%
See 1 more Smart Citation
“…This unmasking of an occult disease after initiation of antiretroviral therapy is referred to as immune reconstitution inflammatory syndrome (IRIS). While it is recognised that Kaposi's sarcoma tends to improve with HAART, data regarding the effect of HAART on multicentric Castleman's disease is conflicting [2,3] . While some report successful treatment of the condition with HAART alone, others claim that multicentric Castleman's disease does not regress with HAART alone [2][3][4] .…”
Section: Case Presentationmentioning
confidence: 99%
“…While it is recognised that Kaposi's sarcoma tends to improve with HAART, data regarding the effect of HAART on multicentric Castleman's disease is conflicting [2,3] . While some report successful treatment of the condition with HAART alone, others claim that multicentric Castleman's disease does not regress with HAART alone [2][3][4] . Several treatment options have been described for multicentric Castleman's disease, however because of the variety of clinical contexts and the rarity of the disease, there is no standard treatment yet.…”
Section: Case Presentationmentioning
confidence: 99%